Noot Walter's Form 4 filing
Usana Health Sciences Inc (USNA) · filed Dec 20, 2021
- Accession no.
- 0001179110-21-011147
- Filed
- Dec 20, 2021
- Trade date
- Dec 16, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $633.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Noot WalterCIK 0001691991 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | Common Stock | MOption exerciseAcquired | +6,193 | $62.20 | +$385,204.6 | 6,193 | Direct | |
| Dec 16, 2021 | Common Stock | SSaleDisposed | −6,193 | $102.25F2 | −$633,234.25 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | Common Stock | MOption exerciseDisposed | −16,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Weighted average price $102.2496. Price range in multiple transactions was $102.00 to $102.69 inclusively.
Referenced by the price of 1 transaction in Table I.